The theme for the conference this year is 'Translation in a fast-changing world'. It's an opportunity to hear about new developments in dementia research and to join discussions about biomarkers, big data and trials delivery – all of which can lead to new disease-modifying treatments for dementia.
Biomarkers for dementia research
Blood-based and imaging biomarkers both have the potential to improve the accuracy by which specific causes of dementia can be diagnosed and cured. In a quickly evolving field, there are numerous possible biomarkers in varying stages of research and development.
Translation 2024 seeks to review currently available biomarkers for the most common forms of neurodegenerative dementia, and gives an overview of research techniques that may in due course make their way into the clinic.
Big Data for Advancing Dementia Research
Dementia is increasing in prevalence and to date has no cure or treatment. One element in improving this situation is using and sharing data more widely to increase the power of research. Translation 2024 will be exploring data sharing initiatives and practices in dementia research and identifying what the most important steps should be to move forwards.
Trials Delivery in Dementia
Barriers to recruitment for dementia studies are well documented. Trials delivery establishes an engine for testing new treatments for dementia to bring the right people to the right place for the right project. Translation 2024 will explore latest developments in implementation and outcomes of dementia research registry in the UK, further discuss existing interventions to understand study participants in clinical registries and referrals.